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ABSTRACT Helothermine, a protein from the venom of the Mexican beaded lizard (Heloderma horridum horridum), was found
to inhibit [3H]ryanodine binding to cardiac and skeletal sarcoplasmic reticulum, to block cardiac and skeletal ryanodine receptor
channels incorporated into planar bilayers, and to block Ca2+-induced Ca2+ release triggered by photolysis of nitr-5 in saponin-
permeabilized trabeculae from rat ventricle. Cloning of the helothermine cDNA revealed that the protein is composed of 223
amino acids with a molecular mass of 25,376 daltons, and apparently is stabilized by eight disulfide bridges. The peptide
sequence showed significant homology with a family of cysteine-rich secretory proteins found in the male genital tract and in
salivary glands. The interaction of helothermine and ryanodine receptors should serve to define functional domains within the
channel structure involved in the control of Ca2+ release from sarcoplasmic reticulum.
INTRODUCTION
The structure of the tetrameric ryanodine receptor and its
associated Ca2" channel function are critical in understand-
ing how Ca2" signals are generated inside cells. In muscle,
this channel controls the release of Ca2" from intracellular
stores when cells are stimulated by voltage and inotropic
agents (Coronado et al., 1994). A similar functional role is
suspected in many other cell types where ryanodine receptors
are expressed (Sorrentino and Volpe, 1993; McPherson and
Campbell, 1993; Coronado et al., 1994). Structural features
of the tetrameric receptor include four radial canals or path-
ways that apparently empty into the myoplasm and that con-
nect together to form a single pathway that empties into the
sarcoplasmic reticulum (SR) lumen (Wagenknecht et al.,
1989). Whether these features represent the true pathways for
Ca2" flow and, thus, are part of the pore structure, is un-
known. Domains within the peptide sequence of the ryano-
dine receptor that form binding sites for Ca2" and ryanodine,
two ligands that affect the gating state of the protein, also
have been identified (Chen et al., 1992; Callaway et al.,
1994). So far, the alkaloid ryanodine is the only molecular
probe of the channel's structure because it is highly specific
and its binding kinetics are sensitive to ligands that open and
close the channel (Wang et al., 1993). Purification and mo-
lecular characterization of additional ligands affecting spe-
cific domains of the ryanodine receptor should provide clues
about the pore structure, conformational states, and ligand-
binding sites controlling Ca2+-induced Ca2' release.
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Peptide toxins targeted against ion channels are ideally
suited to relate channel structure to ion flow and gating
(MacKinnon and Miller, 1989; Giangiacomo et al., 1993).
Although a majority of toxins interact with channels of sur-
face membranes (Adams and Swanson, 1994), some scor-
pion venoms contain peptides specifically targeted against
intracellular channels such as the ryanodine receptor
(Valdivia et al., 1991, 1992). Here we report that helother-
mine, a peptide toxin from the salivary secretion of the Mexi-
can beaded lizard Heloderma horridum horridum (Mochca-
Morales et al., 1990), also appears to target the ryanodine
receptor. Molecular cloning established that helothermine is
different from other peptide toxins because its primary struc-
ture seems to be unrelated to toxins of Na+, K+, or other
channels. In previous studies, a target site for helothermine
could not be identified because the toxin did not interact with
any of the known cardiac muscle cell ionic currents, includ-
ing the voltage-dependent Na+ and Ca21 currents (Mochca-
Morales et al., 1990).
MATERIALS AND METHODS
Purification of helothermine
Helothermine was purified from the salivary secretion of animals kept alive
in the laboratory as described previously (Mochca-Morales et al., 1990).
Pure toxin was reduced and carboxymethylated (Martin et al., 1988). Pep-
tidic fragments were generated by cyanogen bromide cleavage and by tryptic
digestion as described previously (Possani et al., 1985; 1992). Peptides were
separated by HPLC, and their amino acid sequences were obtained by au-
tomatic Edman degradation using an Applied Biosystems microsequencer
(model 470A, Foster City, CA).
Molecular cloning of helothermine
RNA was prepared from the salivary glands of the Mexican beaded lizard
Heloderma horridum horridum after the guanidinium isothiocyanate pro-
cedure according to Sambrook et al. (1989). Poly(A)+ RNA was obtained
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after double-affinity chromatography on oligo(dT) cellulose columns (Phar-
macia, Piscataway, NJ) and used as a template for cDNA synthesis. After
size selection for fragments greater than 500 bp, the cDNA was introduced
into the Uni-ZAP vector (cDNA synthesis kit; Stratagene, La Jolla, CA),
thereby generating a library of 9 X 106 independent clones after packaging.
About 105 recombinant phages were plated and transferred onto nylon filters
(GeneScreen Plus, DuPont NEN, Boston, MA) before screening with oli-
godeoxynucleotide probes derived from the sequence of internal fragments
of purified helothermine (beginning at positions 126 or 11,, respectively,
Fig. 7 A). The sequences of the probes were: 5'-GGITGTGCIATIGCITA-
(C/T)TGCCCIGATCA(A/G)CCIACITACAA (corresponding to amino ac-
ids 130-143); and 5'-AACCCIGATCA(A/G)CA(A/G)ACIGA(A/G)ATI-
ACIGATAA(A/G)CACAACAA (corresponding to amino acids 13-26).
Labeling was carried out using the polynucleotide kinase (Boehringer
Mannheim, Indianapolis, IN) and [T-32P]ATP (Amersham, Arlington
Heights, IL). Hybridization and washing were at conducted at 42°C in the
buffers recommended by the manufacturer. A total of 33 clones giving
positive signals after two rounds of screening were subjected to in vivo
excision and checked for insert size. Ten candidate clones were sequenced,
and the one bearing the longest helothermine cDNA insert was fully ana-
lyzed. The complete DNA sequence of both strands was determined by the
dideoxy chain-termination method according to Sanger et al. (1977) using
a Sequenase Version 2.0 kit (United States Biochemical, Cleveland, OH)
and internal, helothermine cDNA-specific primers.
Sequence analysis of homologous proteins
Sequence analysis was performed using the University of Wisconsin GCG
package according to Devereux et al. (1984). GenBank accession number
of proteins found to be homologous to helothermine are shown in paren-
thesis; mouse CRISP-1/AEG-1 (LO5559) and CRISP-3/AEG-2 (LO5560)
(Mizuki and Kasahara, 1992; Haendler et al., 1993); rat DE/AEG (PIR
accession number A24609) (Brooks et al., 1986; Charest et al., 1988); hu-
man TPX1 (B33329) and mouse TPX-1 (A33329) (Kasahara et al., 1989;
Mizuki et al., 1992); white-face hornet (Dolichovespula maculata) antigen
5/2 (PIR accession number A31085) (Fang et al., 1988); antigen 5 from
paper wasp (Polistes exclamans; A37329) and eastern yellow jacket
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FIGURE 1 Electrophoretic analysis of purified helothermine. Coomassie
Blue staining of SDS gel containing 12.5% polyacrylamide. (lane 1) 80 ,ug
of soluble venom of Heloderma horridum horridum; (lane 2) 4 ,ug of pu-
rified helothermine (HLTX). (lane 3) Molecular weight markers. A.P. is the
sample application point. T.D. marks the tracking dye.
(Vespula maculifrons; B37329) (Lu et al., 1993); red imported fire ant (So-
lenopsis invicta) venom allergen Sol i III (B37330) (Hoffman, 1993); to-
bacco PR-la (PIR accession number S00513) (Cornelissen et al., 1987;
Pfitzner et al., 1988); tomato PR P6(S26239) (Van Kan et al., 1992); maize
PR-like protein (S14969) (Casacuberta et al., 1991); barley PR-1 (S32002)
(Muradov et al., 1993); mouse-ear cress (Arabidopsis thaliana) PR-1
(JQ1693) (Uknes et al., 1992); pSc7 (PIR accession number S27448)
(Schuren et al., 1993).
Purification of SR
Skeletal heavy SR from rabbit leg and back muscle was prepared as de-
scribed previously (Valdivia et al., 1992). Total cardiac microsomes were
prepared from pig ventricular myocardium as described previously (Con-
nelly and Coronado, 1994). [3H]ryanodine binding was performed in du-
plicate samples (50 jig protein each) incubated for 120 min at 360C in 0.1
ml of 7 nM [3H]ryanodine, 0.2 M KCI, 20mM Tris-HEPES, pH 7.2, 1 mM
EGTA plus 1.25 mM CaCl2 ('10 ,uM free Ca2"). Specific [3H]ryanodine
binding under optimal conditions (1 M KC1, 100 ,uM Ca2+, 5 mM ATP, 100
nM [3H]ryanodine) was 15.5 ± 2.3 pmol/mg. [3H]PN200-110 binding was
performed in duplicate samples of rabbit skeletal muscle transverse tubules
and cardiac microsomes incubated for 40 min at room temperature (22-
24°C) in 0.4 nM [3H]PN200-110, 50 mM Tris-Cl, pH 7.2, as described
previously (Valdivia et al., 1990).
Planar bilayer recordings
Planar bilayer formation and recording was performed as described previ-
ously (Coronado et al., 1992). The cis (cytosolic) solution composed of 240
mM CsCH3SO3, 10 mM CsCl, and 10mM HEPES titrated with Tris to pH
7.2. The trans (lumenal) solution was 40mM CsCH3SO3, 10mM CsCl, and
10 mM HEPES titrated with Tris to pH 7.2. The contaminant-free Ca21 of
the cis solution was in the range of 1-3.6 ,uM and was measured by Ca21
electrode.
Permeabilization of rat ventricular trabeculae and
flash photolysis of nitr-5
Thin (150-180 ,um in diameter), unbranched trabeculae were dissected from
adult rat hearts and were placed for 30 min (22-24°C) in relaxing solution
containing 50 ,ug/ml saponin as described previously (Patel et al., 1994).
Trabeculae were stretched to produce an initial resting tension of about
6-10% P., i.e., the maximum active tension elicited in solution of pCa 4.5.
The SR was loaded with Ca2+, and the loaded Ca21 was released subse-
quently by rapid photogeneration of trigger Ca21 from nitr-5. This was done
by sequentially bathing the trabeculae in: 1) Ca2+-depleting solution con-
taining 25mM caffeine and 5mM EGTA for 1 min; 2) Preactivating solution
(PAl) for 1 min; 3) Preactivating solution (PA2) for 1 min. PAl and PA2
reduced the Ca2+-buffering capacity of the relaxing solution wetting the
tissue; 4) Ca2+-loading solution (L), containing 0.37 mM total Ca2' buffered
with 0.7 mM nitr-5, for 5 min. Trabeculae were then exposed to a flash of
UV light (360 nm, 85-100 mJ) from a xenon flash lamp to generate trigger
Ca21, which induced transient Ca2+-induced Ca2' release from the SR. Once
the tension transient was completed, the residual Ca21 content of the SR was
assessed by placing the trabeculae in caffeine-activating solution containing
10 mM caffeine and 0.05 mM EGTA. Finally, the trabeculae were returned
to relaxing solution for at least 2 min.
Relaxing, PA1, PA2, Ca2+-depleting, and caffeine-activating solutions
contained in mM: 100 BES, 25 creatine phosphate, 5.3 MgATP, 1 free Mg2+,
and 1 dithiothreitol. Ionic strength was 180 mM, and pH was 7.0 at 22°C.
In addition, relaxing solution contained 5mM EGTA and 2.6 mM potassium
propionate; PAl contained 0.1 mM EGTA and 16.8 mM potassium pro-
pionate; PA2 contained 0.01 mM EGTA and 17.1 mM potassium propi-
onate; Ca2+-depleting solution was relaxing solution plus 25 mM caffeine;
caffeine-activating solution had 0.05mM EGTA, 16.96mM potassium pro-
pionate, and 10 mM caffeine. The Ca2"-loading solution contained 100 mM
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BES, 14.5 mM creatine phosphate, 4 mM MgATP, 1 mM free Mg2+, and
1 dithiothreitol plus 0.7 mM nitr-5 and 0.37 mM total Ca2' and 56.9 mM
potassium propionate. Assuming a Kd of 145 nM for nitr-5, the free Ca2+
in the loading solutions was calculated to be 160 nM.
Chemicals and abbreviations
[3H]ryanodine and [3H]PN200-110 (1 Ci/mmol) were from DuPont NEN.
Nitr-5 and ryanodine were from Calbiochem (La Jolla, CA). Other reagents
were from Sigma Chemical Co. (St. Louis, MO). BES (N,N-bis(2-
hydroxyethyl)-2-aminoethanesulfonic acid; MES (2-[N-morpholino]
ethane-sulfonic acid); PIPES (Piperazine-N,N'-bis-2-ethanesulfonic acid).
RESULTS AND DISCUSSION
Helothermine characterized in the present study was purified
by gel exclusion and ion-exchange chromatography as a
single polypeptide of molecular mass 25,500 Da (Fig. 1).
After purification, the protein could be lyophilized without
loss of toxic activity and was devoid of phospholipase A2
activity, which is prominent in the crude venom (Sosa et al.,
1986). Previous studies showed that the physiological effects
observed in rodents injected with purified helothermine are
lethargy, rear limb paralysis, hypothermia, and death
(Mochca-Morales et al., 1990). The paralyzing effect sug-
gested that one target of this toxin is excitation-contraction
coupling. We investigated, therefore, whether helothermine
was capable of interacting with receptors controlling this
process. Dihydropyridine receptors in the plasma and trans-
verse tubular membranes and ryanodine receptors in the
junctional SR membrane are thought to be involved directly
in excitation-contraction coupling of cardiac and skeletal
muscle (McPherson and Campbell, 1993). Fig. 2 shows that
purified helothermine produced a strong inhibition of [3H]-
ryanodine binding to SR without affecting the binding of
[3H]PN200-110 to skeletal or cardiac dihydropyridine re-
ceptors. Skeletal SR and transverse tubules (circles) and car-
diac microsomes (triangles) were incubated with 7 nM [3H]-
ryanodine or 0.4 nM [3H]PN200-110 in the presence of the
indicated concentrations of helothermine. The specific bind-
ing of [3H]ryanodine and [3H]PN200-110 in the absence of
toxin was normalized to 100% in each case. Helothermine
inhibited -50% of the binding of [3H]ryanodine to skeletal
SR at a concentration of 5 jig toxin/ml or -200 nM. The
interaction of helothermine with the skeletal ryanodine re-
ceptor was complex because the dose-dependence curve
(filled circles) consisted of at least two components. A high
affinity component inhibited -60% of [3H]ryanodine bind-
ing with an apparent toxin affinity of -20 nM. A component
with a lower toxin affinity, inhibited [3H]ryanodine binding
in the micromolar range. In cardiac SR, helothermine in-
hibited [3H]ryanodine binding in the micromolar range, and
the dose-dependence curve was much steeper than in skeletal
SR. The multiphasic toxin dose-dependence observed in
skeletal SR and the highly steep dose-dependence observed
in cardiac SR suggested that several interacting toxin binding
sites are present in the ryanodine receptor.
We performed several receptor-binding and flux assays to
determined whether helothermine selectively inhibited ry-
anodine receptors. As indicated above, [3H]PN200-110
binding to the cardiac or skeletal dihydropyridine receptor of
the voltage-dependent Ca21 channel was not affected by he-
lothermine even at extremely high concentrations (Fig. 2).
The lack of interaction of helothermine with the Ca21 channel
100-
FIGURE 2 Displacement of [3H]ryanodine
from skeletal and cardiac SR by helothermine.
[3H]ryanodine binding in skeletal SR (n = 4) or
cardiac SR (n = 2) and [3H]PN200-110 binding
in skeletal transverse tubules (n = 2) or total
cardiac microsomes (n = 2) was performed
in the presence of the indicated helothermine
concentrations.
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FIGURE 3 Reversible inhibition of [3H]ryanodine binding by helother-
mine. In prewash, skeletal SR was incubated for 15 min in binding buffer
without (C) and with 10 ,uM helothermine (HLTX) followed by incubation
of both samples with 7 nM [3H]ryanodine. In postwash, skeletal SR was
incubated during 15 min without (C) and with 10 ,AM helothermine (HLTX)
followed by pelleting and resuspension of both samples twice with binding
buffer without toxin followed by incubation with 7 nM [3H]ryanodine.
dihydropyridine receptor was consistent with whole cell
voltage-clamp studies, demonstrating that helothermine did
not affect L-type Ca2" currents in ventricular myocytes
(Mochca-Morales et al., 1990). Other membrane currents of
cardiac cells, such as the voltage-dependent Na+ current was
not affected by helothermine as well (Mochca-Morales et al.,
1990). In addition, a concentration of 40 ,uM helothermine
which, according to Fig. 2, inhibited 80% of [3H]ryanodine
binding to skeletal receptors, did not affect the binding of 30
nM [3H]ouabain to the Na+/K+ pump of rabbit skeletal
muscle transverse tubules (0.46 ± 0.05 pmol/mg in control
and 0.51 ± 0.03 pmol/mg with toxin). 45Ca2+ flux assays
showed that 40 ,uM helothermine did not affect the rate of
ATP-dependent Ca2+ uptake into rabbit skeletal muscle SR
(1.2 ± 0.3 pmol/mg/min in control and 1.02 ± 0.25 pmol/
mg/min with toxin). This result is consistent with experi-
ments described below in which helothermine did not affect
the rate of twitch relaxation after photolysis of caged Ca21
in trabeculae of rat ventricle (Fig. 6). Taken together, these
results suggested that helothermine interacted with ryano-
dine receptors in a rather selective manner because high con-
centrations of helothermine neither displaced drug binding
from other muscle receptors nor affected the activity of the
Ca21 pump which, in skeletal muscle, is present at a much
higher density than that of ryanodine receptors. As shown in
Fig. 3, the inhibition of [3H]ryanodine binding was reversible
as demonstrated by the fact that removal of helothermine by
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FIGURE 4 Block of skeletal ryano-
dine receptor by helothermine. Re-
cordings from the same channel be-
fore (A) and after (B) cis addition of
1.3 ,uM helothermine at 0 mV. (C) A
total of 160 s of continuous recordings
before and after addition of helother-
mine were divided into 683 ms inter-
vals. P. in each interval is plotted as
a bar of length 0 to 1. Average P. dur-
ing the control and test periods are in-
dicated by the horizontal gray line.
(D) A total of 80 s before and after
addition of helothermine were divided
into intervals of 683 ms. P0 in each
interval was added to that of the pre-
vious one, and the cumulative sum
was plotted as a function of recording
time.
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extensive wash of the SR sample before incubation with
[3H]ryanodine restored the binding activity to the control
value.
The functional consequences of the interaction of helo-
thermine with the ryanodine receptor were investigated in SR
incorporated into planar bilayers. Fig. 4 shows the single-
channel activity of a skeletal ryanodine receptor before and
immediately after addition of toxin to the cis solution. He-
lothermine (1.3 ,M) produced a strong inhibition of activity
manifested in a decrease in open probability and a decrease
in mean open time. Open channel probability PO was moni-
tored during 80 s before and after toxin addition. Average PO
decreased approximately sixfold, from 0.34 during the con-
trol period to 0.06 during the test period. As shown in Fig.
4 C (bottom left), the most significant effect of helothermine
was a decrease in the number of burst periods during which
PO remains at a relatively high level. The decrease in activity
was quantified in Fig. 4 D (bottom right) as a graph of cu-
mulative P0 as a function of recording time. In this plot, PO
was averaged during intervals of 683 ms for a total recording
time of at least 75 s in each condition. The open probability
(A)
of each interval was added to that of the next interval, and
the cumulative sum was plotted as a function of time. The
slope of the plot is proportional to the number and duration
of open events per unit time. From this plot, it is apparent that
helothermine produced a constant inhibition that was not
relieved with time of exposure. The inhibition by helother-
mine resulted in a decrease in the mean open channel du-
ration from 1.1 to 0.37 ms and a significant increase in the
mean closed channel duration (not shown). The same pro-
tocol was used in Fig. 5 to demonstrate block of a cardiac
ryanodine receptor from porcine SR. At approximately the
same concentration of toxin used for skeletal channels (1
,uM), helothermine produced a twofold decrease in the P0 of
the cardiac channel during the same monitoring period. Thus,
the inhibition of the cardiac ryanodine receptor by helother-
mine was much weaker than that of the skeletal channel. In
addition, a comparison of Figs. 4 D and 5 D indicated that
the inhibition of the cardiac channel had a longer lag period
than that of the skeletal channel. The much stronger blockade
of skeletal ryanodine receptors by micromolar helothermine
was consistent with the dose-response curves of [3H]ryano-
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FIGURE 5 Block of cardiac ryano-
dine receptor by helothermine. Re-
cordings from the same channel be-
fore (A) and after (B) cis addition of
1 ,uM helothermine at 0 mV. (C) A
total of400 s of continuous recordings
before and after addition of helother-
mine were divided into 683-ms inter-
vals. PO in each interval is plotted as
a bar of length 0 to 1. Average PO dur-
ing control and test periods are indi-
cated by the horizontal gray line. (D)
A total of 150 s before, and 250 s after,
addition of helothermine were divided
into intervals of 683 ms. P. in each
interval was added to that of the pre-
vious one, and the cumulative sum
was plotted as a function of recording
time.
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dine binding (Fig. 2), which indicated that 1 ,AM helother-
mine inhibited a much larger percent of alkaloid binding to
the skeletal than to the cardiac receptor. The underlying
mechanism of channel inhibition by helothermine appeared
to be similar in cardiac and skeletal receptors because, in both
cases, there was a decreased mean open duration and the
appearance of long quiescent periods. The fact that open
times were strongly affected by helothermine tended to rule
out a mechanism of inhibition based on an occlusion on the
open channel, as described for K+ channel toxins (Valdivia
et al., 1988). However, it is possible that helothermine lowers
the Ca21 sensitivity of the channel because this mechanism
will also inhibit the binding of [3H]ryanodine to the receptor.
To determine whether helothermine was capable of block-
ing ryanodine receptors in situ, we investigated the effect of
the toxin on the release of Ca2+ from the SR of saponin-
permeabilized ventricular trabeculae of rat myocardium. SR
Ca2' release was assessed by measurements of isometric ten-
sion and was induced by a trigger Ca21 generated as a result
of flash photolysis of nitr-5 (Patel et al., 1995). Fig. 6A shows
photolysis-induced tension transients recorded in the absence
and presence of 1 ,uM helothemine. In the presence of he-
lothermine, there was a 50% reduction in the amplitude of
the tension transient elicited by flash photolysis. In control
experiments, the amplitude of the tonic tension generated by
pCa 4.5 as well as the caffeine-elicited tension transient,
remained unaffected by helothermine (data not shown). This
indicated that the decrease in the amplitude of the tension
transient produced by helothermine was due neither to a de-
crease in the Ca21 sensitivity of the myofilament nor to a
decrease in the amount of Ca2' available for release. Fur-
thermore, Fig. 6 B indicated that the kinetics of the tension
transient after flash photolysis of nitr-5 were not affected by
helothermine. Because the rate of rise and fall of tension
reflects the rate of rise and fall of the Ca21 transient (Endoh
and Blinks, 1988), this result would indicate that helother-
mine selectively decreased the number of release sites af-
fecting neither the kinetics of activation of the Ca2' release
channel nor the kinetics of Ca2' re-uptake by the Ca2+ pump.
The complete amino acid sequence of helothermine as
deduced after the cloning of the corresponding cDNA is
shown in Fig. 7 A. Five stretches of this sequence (repre-
sented in bold) were originally obtained by amino acid de-
termination of fragments generated by chemical cleavage or
tryptic digestion. Oligodeoxynucleotide probes were synthe-
sized according to the peptidic sequence and were used to
screen a cDNA library, constructed from salivary gland
mRNA of Heloderma horridum horridum. This allowed us
to isolate a full length helothermine cDNA clone. DNA se-
quencing revealed the presence of a 1104-nucleotide-long
insert (not shown; GenBank accession number U13619) con-
taining an open reading frame coding for a 242-amino-acid
protein, which included all of the stretches previously de-
termined by peptide cleavage. A hydrophobic signal peptide
of 19 amino acids was present in the precursor as deduced
from the N-terminal sequence of the mature protein. No po-
tential N-glycosylation site was found. A salient feature of
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FIGURE 6 Inhibition by helothermine of SR Ca2+ release initiated by
flash photolysis of nitr-5 in saponin-permeabilized ventricular trabeculae.
Trabeculae were incubated for 5 min in loading solution (375 ,uM Ca2+, 700
,uM nitr-5) with and without 1 ,uM helothermine. The time before the flash
(F) corresponds to the last 10 s of the loading period. (A) Tension is relative
to the maximum tension generated by the trabeculae at pCa 4.5. (B) Tension
is relative to the peak tension after photolysis.
the protein is its unusual richness in cysteine residues (a total
of 16 for the mature protein), with 10 of them clustered in
the C-terminal 54 residues.
None of the known Na+, K+, or Ca21 channel-specific
toxins recently cataloged (Adams and Swanson, 1994) were
found to share structural similarities with helothermine.
However, a number of proteins not known to affect channels
exhibited significant homology with helothermine (Fig. 7 B).
The highest identities were found with a family of cysteine-
rich secretory proteins (CRISP) described in human and
mouse testis (TPX1 and Tpx-1; 49.6 and 46.7%), mouse sali-
vary gland (CRISP-3, alternative name AEG-2; 41.5%), and
mouse and rat epididymis (CRISP-1/AEG-1 and DE/AEG;
45.5% and 46.3%) (Brooks et al., 1986; Charest et al., 1988;
Kasahara et al., 1989; Mizuki and Kasahara, 1992; Mizuki
et al., 1992; Haendler et al., 1993). Helothermine and CRISP
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FIGURE 7 Amino acid sequence of helothermine deduced from the cDNA nucleotide sequence (GenBank accession number U13619). (A) Boldface letters
indicate amino acid residues determined by Edman degradation of the purified protein (residues 1-20) and of isolated peptide fragments obtained after tryptic
digestion (69-81, 126-143, 144-157, and 165-189) or cyanogen bromide cleavage (11-35). The 16 cysteine residues of the mature protein are highlighted
by asterisks. (B) Amino acid sequence alignment of helothermine with the other known members of the CRISP family and with the more distantly related
proteins of the antigen 5/Sol i III, pathogenesis-related protein 1, and pSc7 from basidomycete fungus Schizophyllum commune. The upper consensus line
shows residues conserved in at least five of the six CRISPs, and vertical bars indicate residues invariant within the CRISP family. Entries in the lower consensus
line indicate positions with agreement in at least 10 of the 16 protein sequences, whereas asterisks mark the 19 invariant residues of the superfamily.
proteins share 16 invariant cysteine residues that are sug-
gestive of a common pattern of disulfide bridges. A weaker,
but still significant, similarity exists with insect venom sac
proteins of the antigen 5/Sol i III family (Fang et al., 1988;
Lu et al., 1993; Hoffman et al., 1993a, b), with pathogenesis-
related proteins from various plants (Cornelissen et al., 1987;
Pfitzner et al., 1988; Casacuberta et al., 1991; Van Kan et al.,
1992; Uknes et al., 1992; Muradov et al., 1993), and with the
fruit body-specific proteins from the basidomycete fungus
Schizophyllum commune (Schuren et al., 1993). These insect,
plant, and fungus proteins lack the cysteine-rich C-terminal
moiety characteristic of the CRISP family. In addition, only
three out of the six cysteine residues of the N-terminal moiety
of helothermine and CRISP proteins were invariant in the
antigen 5, PR, and pSc proteins. On the other hand, all of the
proteins shared a common core stretch (GHYTQVVW) cor-
responding to residues 116-123 of helothermine.
Although proteins related to helothermine appear to be
present in basidomycete fungus, plants, insects, and mam-
mals, their function(s) is virtually unknown. In mammals, the
epididymal glycoprotein CRISP-1 (DE/AEG) appears to be
involved in sperm maturation (Brooks et al., 1986; Charest
et al., 1988; Kasahara et al., 1989; Mizuki et al., 1992; Mizuki
and Kasahara, 1992; Haendler et al., 1993) In plants, a partial
resistance against pathogenic comycete fungi has been ob-
served for transgenic tobacco constitutively expressing
pathogenesis-related protein PR-la (Alexander et al., 1993).
Here we identified helothermine as a new member of the
CRISP family of proteins and suggested that the ryanodine
receptor is a target of this protein in striated muscle. Because
CRISP proteins are present in mammalian tissues, the pos-
sibility that CRISP-like proteins endogenously regulate ry-
anodine receptors must also be considered.
With regard to the toxic action of helothermine in rodents,
it is unlikely that exogenous helothermine reaches ryanodine
receptors in muscle unless it is assisted by other components
of Heloderma venom, such as phospholipase A2 (Sosa et al.,
1986), to facilitate diffusion of helothermine across the sur-
face membrane. Also, it cannot be excluded that a
membrane-permeable fragment of helothermine produced by
cleavage of the whole protein penetrates muscle cells to pro-
duce a direct block of the ryanodine receptor. In cell
membrane-free preparations such as skinned muscle cells
used here, helothermine should become a powerful probe of
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ryanodine receptor structure and function because helother-
mine was capable of overriding Ca2"-dependent activation of
SR Ca2" release.
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